MANILA (Bloomberg): Covid-19 patients in the Philippines may get early access to Merck & Co’s yet to be approved anti-viral treatment pill for a few dollars starting in November with a compassionate special permit.
Filipino-owned importer MedEthix Inc. and distributor JackPharma Inc. said in a joint statement Wednesday that they will bring molnupiravir to hospitals in the Philippines as early as next month. They plan to distribute pills manufactured by India’s Aurobindo Pharma Ltd. through a licencee agreement with Merck.